According to the results from Western blot analysis, in comparison to that in control cells, ERK1/2 phosphorylation was markedly decreased in all tested tumor cells exposed to bestatin in a time- and dose-dependent manner (*P < 0.05; **P < 0.01) (Figure 5A and 5B). Here, MAPK3 is linked to neoplasm.